TYM-3-98 induces ferroptotic cell death in KRAS-mutant CRC cells via inhibition of the oncogenic PI3K–AKT pathway, while the overexpression of SREBP1 results in resistance of CRC cells to TYM-3-98-induced ferroptosis. Here, KRAS is linked to colorectal carcinoma.